health · HHS-NIH11
Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-26-002
Award Range
$3.5M – $4.0M
Total Program Funding
$6.2M
Expected Awards
1
Deadline
TBD
GRANTQUICK SUMMARYPlain-English Overview
Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed). National Institutes of Health. The National Institute of Neurological Disorders and Stroke (NINDS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to investigate novel therapeutic interventions and testing strategies for neurological disorders including to treat, modify, and prevent epilepsy.... $3,500,000-$4,000,000 per award; $6,200,000 total program funding; ~1 awards expected.
Who Should Apply
Other Native American Tribal Organizations, Public universities/colleges, Federally Recognized Native American Tribal Governments, State governments, Nonprofits (501c3) (+10 more)
Who Should NOT Apply
Organizations not matching the eligible applicant types listed above
Key Requirements (Plain English)
- •Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U
💡 GrantQuick Tip
High-value award — invest significantly in proposal quality. Consider hiring a grant writer.
Competitiveness: Very high — extremely limited awards available
What This Grant Funds
The National Institute of Neurological Disorders and Stroke (NINDS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to investigate novel therapeutic interventions and testing strategies for neurological disorders including to treat, modify, and prevent epilepsy. This research should include various intervention modalities and testing strategies. Investigators should consider testing strategies for the development and validation of human-focused testing approaches. Investigators with expertise and insights into preclinical therapy testing and model development are encouraged to consider applying for this new NOFO.
Who Can Apply
Eligible Applicant Types
Funding Details
- Minimum Award
- $3.5M
- Maximum Award
- $4.0M
- Total Program Funding
- $6.2M
- Expected Number of Awards
- 1
- Cost Sharing Required?
- No
- Funding Instrument
- cooperative_agreement
Key Dates
Agency Contact
Brian Klein, PhD (301) 496-0981
brian.klein@nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov